On-line nuovi materiali! 📚Confronto del valore prognostico e predittivo dell’espressione genica immuno relata vs infiltrato linfocitario tumorale nel ca. mammario HER2+ in stadio precoce - A cura di Z. Ballatore (AN) tinyurl.com/2nsrysex jamanetwork.com/journals/jamao… JAMA Oncology

I DUBBI DI MARTA | Podcast Le risposte della BCA alle domande delle pazienti 🔗tinyurl.com/4m5xj26t 🔊 24 - Cos'è l'immunoterapia e quando si usa nel tumore della mammella? Risponde alessia rognone #breastcancer #Immunotherapy open.spotify.com/episode/7K2bOv…

One of the most thought provoking and brilliant works in the HER2-low space. 👉most patients with HER2-neg MBC simultaneously harbor both HER2-0 and HER2-low lesions, even within the same organ. Congrats Tatjana Geukens & colleagues for the publication! ejcancer.com/article/S0959-…

In case you missed it! 👉Landmark #POSITIVE study published in NEJM by Dr. Ann Partridge and colleagues which helps us understand the impact of Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer. #breastcancer #bcsm #pregnancy pubmed.ncbi.nlm.nih.gov/37133584/

HER2: bersaglio mobile? tinyurl.com/2kjksw4n

Great talk by @prat_aleix on HR+/HER2 BC biomarkers. My fav part: basal-like and immunogenic phenotypes can be found in HR+/HER2- too (even in ER>10%!), and are associated with 👎response to endocrine tp and 👍 response to chemo (and maybe IO) #ESMOBreast23

Jee Hyun Kim at #ESMOBreast23 on biomarker-driven strategies in HER2+ BC. Genomic biomarkers predict prognosis beyond clinical factors. Assays integrating both like #HER2DX can better guide tx. More evidence available at the poster display tomorrow at 12.15 REVEAL GENOMICS

Outstanding Fara Brasó Maristany at #ESMOBreast23 on HER2/ERBB2 mRNA leves and response to HER3-DXd in SOLTI #cancerresearch TOTHER3 trial Lower ERBB2 👉better response from HER3-DXd Biological explanation still unknown. Maybe the answer is the HER2-HER3 dimerization affecting HER3 stability?

Impact of the endocrine resistance/sensitivity classification according to consensus guidelines for advanced #BreastCancer Findings provide evidence on prognostic and clinical impact of the currently adopted classification in HR+/HER2− advanced BC bit.ly/3MQVul5

Si è concluso il 19th Meet The Professor | Advanced International Breast Cancer Course (AIBCC). Un ringraziamento speciale va ai Resp. Scientifici Pierfranco Conte, Valentina Guarneri, Philip Poortmans e @prat_aleix Prat e ai membri del Comitato Scientifico Internazionale.

Happy to share at #ESMO23 our work (2239P) on gene signatures capturing tertiary lymphoid structures (TLS) from pts prescreened at @SOLTI ACROPOLI trial ➡️ 14-gene B-cell signature IGG strongly associated with TLS across cancer types! @prat_aleix Tomás Pascual Hospital Clínic

SNPs of aromatase could be useful e biomarkers to personalize both extended andjuvant endocrine treatment and survivorship intervention in patients with ER+ early #breastcancer . Validation needed! ⬇️⬇️⬇️⬇️⬇️

We are so glad to share our immuno-genomic model for HR+/HER2- eBC based on the integrated evaluation of Recurrence Score & TILs. 💡Just out on European Journal of Cancer Maria Vittoria Dieci doi.org/10.1016/j.ejca…

Honoured of presenting the first safety analysis of the GIM26 - TRASTHER study at the oral communication session of #AIOM23 congress. Key topics: real world evidence, post-neoadjuvant T-DM1, safety data Università di Genova @GIM AIOM

WEBINAR LIVE Breast Cancer Academy: le novità da San Antonio 1,5 Crediti ECM | 18 dicembre 2023 ISCRIVITI ORA tinyurl.com/2h88jhfm #breastcancer #SABCS23 #oncology

L’analisi di un gene potrà rivelare il periodo ideale di trattamento per minimizzare i rischi e amplificare i benefici in ogni donna colpita da tumore al seno positivo per i recettori ormonali. Studio finanziato da Ministero della Salute Leggi di più 👇 ospedalesanmartino.it/it/ricerca-sci… AACR

🔬Breaking barriers in #TNBC Unleashing the power of #ADCs 👉🏼 doi.org/10.1016/j.ctrv… Thanks to Arianna Dri and the extraordinary group of coauthors Grazia Arpino Giampaolo Bianchini G Curigliano MD PhD Michelino De Laurentiis Lucia Del Mastro alessandra fabi Alessandra Gennari MD PhD valentina

On-line nuovi materiali! 📚Disponibili i materiali (PDF, video) del webinar di dicembre che ha presentato una selezione di lavori presentati all'ultimo San Antonio Breast Cancer Symposium. tinyurl.com/56phrzhd #breastcancer #SABCS23 #oncology

Very happy to see that our paper on eBioMedicine – The Lancet Discovery Science is the Editor's pick from the April issue! B-cell immunity is finally gaining its spot in the onocoimmunology field. In this paper we show how it is associated with pCR and prognosis in TNBC ⬇️@prat_aleix EVOMET Fara Brasó Maristany

Elena Cecchettin, sorella di Giulia uccisa dall'ex fidanzato Filippo Turetta l'11 novembre 2023, ha continuato a fare rumore per Giulia e a gridare contro una cultura dove «nessun uomo è buono se non fa nulla per smantellare la società che li privilegia tanto». Il 12 maggio Elena